PPAR Research

PPARs in Eye Biology and Disease


Publishing date
01 Jul 2008
Status
Published
Submission deadline
01 Nov 2007

Guest Editors

PPARs in Eye Biology and Disease

Articles

  • Special Issue
  • - Volume 2008
  • - Article ID 518790
  • - Editorial

PPARs in Eye Biology and Disease

Suofu Qin | Roy S. Chuck
  • Special Issue
  • - Volume 2008
  • - Article ID 164273
  • - Review Article

PPAR 𝛾 Agonists: Potential as Therapeutics for Neovascular Retinopathies

Harrihar A. Pershadsingh | David M. Moore
  • Special Issue
  • - Volume 2008
  • - Article ID 821592
  • - Review Article

PPAR- 𝜶 Ligands as Potential Therapeutic Agents for Wet Age-Related Macular Degeneration

Marisol del V Cano | Peter L. Gehlbach
  • Special Issue
  • - Volume 2008
  • - Article ID 720163
  • - Review Article

Prevention of Oxidative Stress-Induced Retinal Pigment Epithelial Cell Death by the PPAR Agonists, 15-Deoxy-Delta 12, 14-Prostaglandin

Jason Y. Chang | Puran S. Bora | Nalini S. Bora
  • Special Issue
  • - Volume 2008
  • - Article ID 825970
  • - Review Article

A Role for PPAR 𝛽 / 𝛿 in Ocular Angiogenesis

David Bishop-Bailey
  • Special Issue
  • - Volume 2008
  • - Article ID 295784
  • - Review Article

PPAR- 𝛾 , Microglial Cells, and Ocular Inflammation: New Venues for Potential Therapeutic Approaches

Fiorella Malchiodi-Albedi | Andrea Matteucci | ... | Luisa Minghetti
  • Special Issue
  • - Volume 2008
  • - Article ID 895901
  • - Review Article

Regulation of Lymphocyte Function by PPAR 𝛾 : Relevance to Thyroid Eye Disease-Related Inflammation

G. M. Lehmann | T. M. Garcia-Bates | ... | R. P. Phipps
  • Special Issue
  • - Volume 2008
  • - Article ID 389507
  • - Review Article

Peroxisome Proliferator-Activated Receptor and Age-Related Macular Degeneration

Alexandra A. Herzlich | Jingsheng Tuo | Chi-Chao Chan
  • Special Issue
  • - Volume 2008
  • - Article ID 679237
  • - Review Article

Role of Peoxisome Proliferator Activator Receptor 𝛾 on Blood Retinal Barrier Breakdown

Yasuo Yanagi
PPAR Research
 Journal metrics
Acceptance rate44%
Submission to final decision48 days
Acceptance to publication38 days
CiteScore7.100
Impact Factor2.953
 Submit

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.